National Institutes of Health Director Francis S. Collins, M.D., Ph.D., today announced the selection of Chris A. Kaiser, Ph.D., as the new director of the National Institute of General Medical Sciences. Kaiser, a leader in cell biology, is professor and head of the Department of Biology at the Massachusetts Institute of Technology. He expects to start his new position in the spring of 2012.
"Dr. Kaiser has tremendous energy and enthusiasm for research and trainingtwo key components of the NIGMS missionthat make him ideal for this position," said Collins. "His scientific vision, leadership skills and collaborative spirit are essential assets that will help him guide the institute during this era of great opportunity."
Kaiser will replace Judith H. Greenberg, Ph.D., who became acting director of NIGMS in July 2011 after the departure of Jeremy M. Berg, Ph.D., who had served as director since 2003.
"Dr. Greenberg is an exceptional leader, and I thank her for this service to NIGMS and NIH," said Collins.
As NIGMS director, Kaiser will oversee the institute's $2 billion budget, which primarily funds basic research in the areas of cell biology, biophysics, genetics, developmental biology, pharmacology, physiology, biological chemistry, bioinformatics and computational biology. NIGMS supports more than 4,500 research grantsabout 10 percent of those funded by NIH as a wholeas well as a substantial amount of research training and programs designed to increase the diversity of the biomedical and behavioral research workforce.
"In taking this position, I feel a compelling call to duty for national service and to be an advocate for the basic research enterprise," said Kaiser. "For 50 years, NIGMS has laid the foundation for important medical advances, and I'm excited to build on these efforts."
Kaiser's research uses genetic, biochemical and structural biology methods to understand the basic mechanisms of prote
|Contact: Ann Dieffenbach|
NIH/National Institute of General Medical Sciences